APA (7th ed.) Citation

W, L., M, C., D, K., H, W., R, T., C, C., & W, Z. (2026). Refining post-neoadjuvant risk stratification in ESCC with lymph node regression grade. Frontiers in oncology, 16, 1723139. https://doi.org/10.3389/fonc.2026.1723139

Chicago Style (17th ed.) Citation

W, Liang, Chen M, Kang D, Wang H, Tong R, Chen C, and Zheng W. "Refining Post-neoadjuvant Risk Stratification in ESCC with Lymph Node Regression Grade." Frontiers in Oncology 16 (2026): 1723139. https://doi.org/10.3389/fonc.2026.1723139.

MLA (9th ed.) Citation

W, Liang, et al. "Refining Post-neoadjuvant Risk Stratification in ESCC with Lymph Node Regression Grade." Frontiers in Oncology, vol. 16, 2026, p. 1723139, https://doi.org/10.3389/fonc.2026.1723139.